Generic Name and Formulations:
Crisaborole 2%; oint.
Anacor Pharmaceuticals, Inc.
Indications for EUCRISA:
Mild-to-moderate atopic dermatitis.
Adults and Children:
<2yrs: not established. ≥2yrs: apply a thin layer twice daily to affected areas.
Not for ophthalmic, oral, intravaginal use. Discontinue immediately if hypersensitivity occurs. Pregnancy. Nursing mothers.
Phosphodiesterase 4 (PDE4) inhibitor.
Application site pain (eg, burning, stinging); hypersensitivity reactions, contact urticaria.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Differences in Efficacy and Tolerability of ADHD Medications Across Age Groups
- Associations Between Hypovitaminosis D and Poorer Outcomes in Schizophrenia
- Oxycontin's Maker Now Selling Drug to Curb Opioid Addiction
- Comorbid Narcolepsy and Schizophrenia in Adolescents
- Ketamine in Electroconvulsive Therapy Accelerates Antidepressive Effects
- Quetiapine Exposure Does Not Appear to Increase Risk for Infant Malformations
- Selective Serotonin Reuptake Inhibitors May Increase Risk for Suboptimal Fetal Growth
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Ketamine Infusions Reduce Suicidal Ideation in Depression: Characterizing Different Responses
- Prenatal Insecticide Exposure in Mother May Be Linked to Risk for Autism in Children